Comments
Loading...
CASI Pharmaceuticals Stock Guidance | NASDAQ:CASI | Benzinga
CASI Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/12/2021 | CASI | CASI Pharmaceuticals | FY | 2021 | — | — | — | $27.25M | — | $28.58M | Get Alert |
FAQ
What is the most recent guidance for CASI Pharmaceuticals (CASI)?
There have been no specific sales or earnings guidance reported for CASI Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.
